The E in ESG: Philips Drives For Science-Based Targets In Carbon Zero Challenge
Becoming The Leading Provider Of Low Carbon Equipment Is A Key Aim For Philips
With a product mix that includes high energy consumption imaging, capital equipment and personal health care, Philips has a unique spectrum of challenges in driving low carbon health care. Nevertheless, it has set the bar high in environmental sustainability goals, and is pressing suppliers to follow its lead.
You may also be interested in...
AstraZeneca was among the first seven companies globally to have its net zero targets verified by the Science-Based Targets initiative’s corporate net zero standard. Investment in green gas, reforestation and the associated use of AI mark the company out as a thought leader in sustainability initiatives. In this context, COP28’s renewed focus on ‘climate+health’ is well timed.
High quality data reporting will be crucial if the healthcare and life sciences sectors are to achieve net zero compliance of carbon emissions. This 12th instalment of In Vivo’s rolling E in ESG series reports on the growing body of disclosure and reporting laws and platforms.
News We’re Watching: Medtronic To Buy EOFLow, Neuralink Cleared For Human Trials, NICE Backs Genetic Tests
This week, Medtronic said it would pay $738m for insulin patch firm EOFlow; Neuralink got an FDA OK for first-in-human trials; and UK agency NICE backed genetic tests for stroke patients and digital therapeutics for mental health conditions.